GlassScriptPhysician profile
Erin Colleen Lytle
NPI 1922236801
$1,311.29
in general payments reported to CMS, 2019-2025
15 companies · $460 in 2025
The $460 reported for 2025 was more than what 91% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.05 · 2022: $105 · 2023: $308 · 2024: $421 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,188.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $309.77 | 2023-2025 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Corium, LLC | $270.44 | 2023-2025 | Azstarys |
| Cranial Technologies, INC | $102.22 | 2022-2025 | Doc Band |
| Aytu Biopharma, INC. | $101.23 | 2024-2025 | Karbinal |
| Pfizer INC. | $89.07 | 2022-2024 | |
| Ars Pharmaceuticals Operations, INC. | $82.10 | 2025 | Neffy |
| Alk-Abello, INC | $68.22 | 2024-2025 | Odactra, Ragwitek, Grastek |
| Ironshore Pharmaceuticals INC. | $57.69 | 2022-2024 | Jornay Pm |
| Tris Pharma INC | $51.89 | 2021-2022 | |
| Seqirus USA INC | $42.18 | 2022-2024 | Flucelvax |
| Merck Sharp & Dohme LLC | $37.07 | 2024-2025 | Gardasil 9, Vaxneuvance, Enflonsia |
| Supernus Pharmaceuticals, INC. | $30.04 | 2024 | Qelbree |
| Vertical Pharmaceuticals, LLC | $26.24 | 2024 | Relexxii |
| Glaxosmithkline, LLC. | $25.61 | 2024 | Bexsero |
| Hologic Sales and Service, LLC | $17.52 | 2025 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Lytle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.